-
公开(公告)号:US20210239664A1
公开(公告)日:2021-08-05
申请号:US17263080
申请日:2019-07-31
申请人: Mie University
摘要: The present invention aims to provide a method for preparing exosomes comprising: (i) a step for ultrafiltering a sample containing at least one exosome; and (ii) a step for subjecting the sample that can be obtained from step (i) to anion exchange column chromatography.
-
公开(公告)号:US11714068B2
公开(公告)日:2023-08-01
申请号:US17263080
申请日:2019-07-31
申请人: Mie University
CPC分类号: G01N30/88 , G01N1/405 , G01N1/4077 , G01N2001/4088
摘要: The disclosure provides a method for preparing exosomes using: (i) a step for ultrafiltering a sample containing at least one exosome; and (ii) a step for subjecting the sample that can be obtained from step (i) to anion exchange column chromatography.
-
公开(公告)号:US11083744B2
公开(公告)日:2021-08-10
申请号:US15559771
申请日:2016-03-18
申请人: MIE UNIVERSITY , KYOTO UNIVERSITY
IPC分类号: A61K31/7105 , A61P35/00 , A61K35/17 , C12Q1/6876 , C12N5/0775 , A61K9/08 , A61K9/00 , A61K45/06
摘要: Therapeutic agents effective for treating cell-proliferative diseases contain extracellular vesicles (exosomes) released from cytotoxic T cells or miRNA obtained from extracellular vesicles (exosomes) released from cytotoxic T cells, such as human CD8+ T cells. Such therapeutic agents suppress the proliferation of mesenchymal cells surrounding cancer cells, e.g., by killing the mesenchymal cells, such that the cancer cells become isolated and unable to metastasize. Cell-proliferative diseases are thus treatable by administering such a therapeutic agent to a patient.
-
-